Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation

Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation

Dihydrofolate reductase (DHFR) is a crucial enzyme that catalyzes the conversion of folic acid. Its reserved properties and significance in both human (h-DHFR) and mycobacterium (mt-DHFR) make it a challenging target for developing drugs against cancer and bacterial infections. Although methotrexate...

Full description

Bibliographic Details
Main Authors:	Ghyzlane EL Haddoumi, Mariam Mansouri, Houda Bendani, Mohammed Walid Chemao-Elfihri, Jouhaina Kourou, Hanane Abbou, Lahcen Belyamani, Ilham Kandoussi, Azeddine Ibrahimi
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-05-01
Series:	Bioinformatics and Biology Insights
Online Access:	https://doi.org/10.1177/11779322231171778

Similar Items

In Silico Analyses of All STAT3 Missense Variants Leading to Explore Divergent AD-HIES Clinical Phenotypes
by: Mariam Mansouri, et al.
Published: (2023-04-01)

Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach
by: EL Haddoumi G, et al.
Published: (2023-04-01)

A Comprehensive Analysis of 3 Moroccan Genomes Revealed Contributions From Both African and European Ancestries
by: Nasma Boumajdi, et al.
Published: (2024-02-01)

Metagenomics Analysis of Breast Microbiome Highlights the Abundance of Rothia Genus in Tumor Tissues
by: Souad Kartti, et al.
Published: (2023-02-01)

Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the “Confined Virus”?
by: Tarek Alouane, et al.
Published: (2020-10-01)

Structural and Dynamics Perspectives on the Binding of Substrate and Inhibitors in Mycobacterium tuberculosis DHFR
by: Pimonluck Sittikornpaiboon, et al.
Published: (2017-09-01)

Identification of Natural Food Compounds as Potential Quorum-Sensing Inhibitors Targeting the LasR Receptor of
by: Meryam Magri, et al.
Published: (2023-11-01)

Pharmacophores and pharmacophore searches /
by: Langer, Thierry, et al.
Published: (2006)

Targeted Gene Panel Sequencing Unveiled New Pathogenic Mutations in Patients With Breast Cancer
by: Souad Kartti, et al.
Published: (2023-06-01)

Regulation of eDHFR-tagged proteins with trimethoprim PROTACs
by: Jean M. Etersque, et al.
Published: (2023-11-01)

Hybrid-drug design targeting pseudomonas aeruginosa DHPS and DHFR
by: Jayaraman, Premkumar, et al.
Published: (2014)

Significant Association of Polymorphisms in the TCF7L2 Gene with a Higher Risk of Type 2 Diabetes in a Moroccan Population
by: Sarah Elhourch, et al.
Published: (2021-05-01)

Using the DHFR heat-inducible degron for protein inactivation in Schizosaccharomyces pombe.
by: Kearsey, S, et al.
Published: (2009)

Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives
by: Suriyawut Kulatee, et al.
Published: (2017-11-01)

Functional analysis and comparative genomics of Rahnella perminowiae S11P1 and Variovorax sp. S12S4, two plant growth-promoting rhizobacteria isolated from Crocus sativus L. (saffron) rhizosphere
by: Rahma ZOUAGUI, et al.
Published: (2024-03-01)

Molecular Docking and Molecular Dynamics Simulation studies of DHFR inhibitors in Plasmodium falciparum
by: Prachi Bhole, et al.
Published: (2017-10-01)

Quinazoline pharmacophore in therapeutic medicine
by: Olayinka Oyewale Ajani, et al.
Published: (2016-08-01)

Towards a partial order graph for interactive pharmacophore exploration: extraction of pharmacophores activity delta
by: Etienne Lehembre, et al.
Published: (2023-11-01)

Identification of DHPS and DHFR of pythium insidiosum from the first Chinese skin and subcutaneous pythiosis
by: Haiyan Zhang
Published: (2023-01-01)

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors
by: M. Akiful Haque, et al.
Published: (2023-01-01)

Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity
by: Jennifer I. Brown, et al.
Published: (2023-01-01)

Identification of natural DHFR inhibitors in MRSA strains: Structure-based drug design study
by: Gagandeep Singh, et al.
Published: (2022-01-01)

Berberine: A Potential Inhibitor of Dihydrofolate Reductase- Thymidylate Synthase (DHFR-TS) for Malaria
by: Yohanes Bare, et al.
Published: (2022-10-01)

Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging
by: Hui Peng, et al.
Published: (2022-05-01)

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.
by: Certain, L, et al.
Published: (2008)

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
by: Imwong, M, et al.
Published: (2001)

Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
by: Eman M. Sayed, et al.
Published: (2024-02-01)

A dhfr-ts- Leishmania major Knockout Mutant Cross-protects against Leishmania amazonensis
by: PST Veras, et al.
Published: (1999-07-01)

Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening
by: Marie Hoarau, et al.
Published: (2021-01-01)

In silico identification of phytochemical inhibitors for multidrug-resistant tuberculosis based on novel pharmacophore generation and molecular dynamics simulation studies
by: Bader S. Alotaibi
Published: (2024-04-01)

Exploring protein hotspots by optimized fragment pharmacophores
by: Bajusz, D, et al.
Published: (2021)

Drug Design by Pharmacophore and Virtual Screening Approach
by: Deborah Giordano, et al.
Published: (2022-05-01)

Slipknot or Crystallographic Error: A Computational Analysis of the <i>Plasmodium falciparum</i> DHFR Structural Folds
by: Rolland B. Tata, et al.
Published: (2022-01-01)

Identification of Active Compounds against Melanoma Growth by Virtual Screening for Non-Classical Human DHFR Inhibitors
by: Andrés Felipe Vásquez, et al.
Published: (2022-11-01)

Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from <it>Plasmodium falciparum</it>
by: Chen Ming, et al.
Published: (2004-06-01)

Novel phytochemical antibiotic conjugates as multitarget inhibitors of pseudomononas aeruginosa GyrB/ParE and DHFR
by: Jayaraman, Premkumar, et al.
Published: (2014)

Significant hydrogen exchange protection in GroEL-bound DHFR is maintained during iterative rounds of substrate cycling.
by: Gross, M, et al.
Published: (1996)

Limited polymorphism in the dihydrofolate reductase (dhfr) and dihydropteroate synthase genes (dhps) of Plasmodium knowlesi isolate from Thailand
by: Sangsri, R, et al.
Published: (2023)

Evaluation of Dihydrofolate Reductase (Dhfr) Gene, Related to Plasmodium Falciparum Pyrimethamine Resistance in Imported Malaria Cases in Iran
by: Seyyed Ali Shariatzadeh, et al.
Published: (2021-11-01)

Disparate selection of mutations in the dihydrofolate reductase gene (dhfr) of Plasmodium ovale curtisi and P. o. wallikeri in Africa.
by: Jing Chen, et al.
Published: (2022-12-01)